Immunotherapy for Advanced HCC: Review of Current Applications and Future Perspectives
1. Abstract Hepatocellular cancer (HCC) remains a disease with an important health burden worldwide. Early diagnosis in combination with favorable individual factors, including a good performance status and liver function allows the performance of surgical and/or locoregional treatment, which can result in an acceptable expected survival.